Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration
XTalks
AUGUST 30, 2022
We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. What About Small Proteins and Antibodies Reaching Extracellular CNS Targets? Next Steps for Targeted CNS Delivery.
83 
Let's personalize your content